Hereditary nonpolyposis colorectal cancer (HNPCC), also referred to as Lynch syndrome, is the most common form of hereditary colorectal cancer and is responsible for 2% to 4% of all colorectal cancers in the Western hemisphere. Generally characterized by early-onset colorectal carcinoma with a mean age of presentation of 40 to 45 years, it can also manifest with extracolonic adenocarcinomas and cancers of the endometrium, ovaries, stomach, pancreas, small intestine, hepatobiliary tract, upper uroepithelial tract, brain, and skin. HNPCC is autosomal dominant and carries an 80% lifetime risk of cancer development. This review addresses the molecular underpinnings of HNPCC while providing a concise approach to clinical detection, diagnosis, and management of patients who may or may not test positive for an HNPCC-causing mutation. Although applicable to any patient-care setting in which cancer may be observed, this review specifically addresses the role of nurses in detecting, diagnosing, and clinically managing HNPCC.
Abdel-Rahman, W., & Peltomäki, P. (2004). Molecular basis and diagnostics of hereditary colorectal cancers. Annals ofMedicine, 36, 379-388.
2.
Akrami, S., Dunlop, M., Farrington, S., Frayling, I., MacDonald, F., Harvey, J., et al. (2005). Screening for exonic copy number mutations at MSH2 and MLH1 by MAPH. FamilialCancer, 4, 145-149.
3.
Annie Yu, H., Lin, K., Ota, D., & Lynch, H. (2003). Hereditary nonpolyposis colorectal cancer: Preventative management. Cancer Treatment Reviews, 29, 461-470.
4.
Balmana, J., Stockwell, D., Steyerberg, E., Stoffel, E., Deffenbaugh, A., Reid, J., et al. (2006). Prediction of MLH1 and MSH2 mutations in Lynch syndrome. Journal of theAmerican Medical Association , 296(12), 1469-1478.
5.
Barnetson, R., Tenesa, A., Farrington, S., Nicholl, I., Cetnarskyj, R., Porteous, M., et al. (2006). Identification and survival of carriers of mutations in DNA mismatch-repair genes in colon cancer. New England Journal of Medicine, 354(26), 2751-2763.
6.
Benatti, P., Gafa, R., Barana, D., Marino, M., Scarselli, A., Pedroni, M., et al. (2005). Microsatellite instability and colorectal cancer prognosis. ClinicalCancer Research, 11(23), 8332-8340.
7.
Brueckl, W., Moesch, C., Brabletz, T., Koebnick, C., Riedel, C., Jung, A., et al. (2003). Relationship between microsatellite instability, response, survival, in palliative patients with colorectal cancer undergoing first-line chemotherapy. Anticancer Research, 23, 1773-1778.
8.
Buttin, B., Powell, M., Mutch, D., Babb, S., Huettner, P., Edmonston, T., et al. (2004). Penetrance and expressivity of MSH6 germline mutations in seven kindreds not ascertained by family history. American Journal of Human Genetics, 74, 1262-1269.
9.
Chen, S., Wang, W., Lee, S., Nafa, K., Lee, J., Romans, K., et al. (2006). Prediction of germline mutations and cancer risk in the Lynch syndrome. Journal of theAmerican Medical Association, 296(12), 1479-1487.
10.
Chung, D., & Rustgi, A. (2003). The hereditary non-polyposis colorectal cancer syndrome: Genetics and clinical implications. Annals of Internal Medicine, 138(7), 560-570.
11.
Church, J. (2005). Invited editorial. Diseases of the Colon and Rectum, 49, 94-95.
12.
Church, J., Kiringoda, R., & LaGuardia, L. (2003). Inherited colorectal cancer registries in the United States: The state of the union. Diseases of the Colon and Rectum, 47(5), 674-678.
13.
Coura, R., Ashton-Prolla, P., & Prolla, J. (2005). Hereditary non-polipomatous colorectal cancer: Hereditary predisposition, diagnosis prevention. Arquivos deGastroenterologia, 42(2), 99-106.
14.
de Jong, A., Morreau, H., Van Puijenbroek, M., Eilers, P., Wijnen, J., Nagengast, F., et al. (2004). The role of mismatch repair gene defects in the development of adenomas in patients with HNPCC. Gastroenterology , 126, 42-48.
15.
de Jong, A., van Puijenbroek, M., Hendriks, Y., Tops, C., Wijnen, J., Ausems, M., et al. (2004). Microsatellite instability, immunohistochemistry, and additional PMS2 staining in suspected hereditary nonpolyposis colorectal cancer. ClinicalCancer Research, 10, 972-980.
16.
de la Chapelle, A. (2005). The incidence of Lynch syndrome. FamilialCancer, 4, 233-237.
17.
de Vos, M., Hayward, B., Bonthron, D., & Sheridan, E. (2005). Phenotype associated with recessively inherited mutations in DNA MMR genes. Biochemical SocietyTransactions, 33(4), 718-720.
18.
Elsaleh, H., & Iacopetta, B. (2001). Microsatellite instability is a predictive marker for survival benefit from adjuvant chemotherapy in a population-based series of stage III colorectal carcinoma. Clinical ColorectalCancer , 1, 104-109.
19.
Engel, C., Forberg, J., Holinski-Feder, E., Pagenstecher, C., Plaschke, J., Kloor, M., et al. (2005). Novel strategy for optimal sequential application of clinical criteria, immunohistochemistry and microsatellite analysis in the diagnosis of hereditary nonpolyposis colorectal cancer. International Journal ofCancer, 118, 115-122.
20.
Grover, S., Stoffel, E., Bussone, L., Tschoegl, E., & Syngal, S. (2004). Physician assessment of family cancer history and referral for genetic evaluation in colorectal cancer patients. Clinical Gastroenterology and Hepatology: The Official Clinical Practice Journal of the American Gastro-enterological Association, 2(9), 813-819.
21.
Guidoboni, M., Gafà, R., Viel, A., Doglioni, C., Russo, A., Santini, A., et al. (2001). Microsatellite instability and high content of activated cytotoxic lymphocytes identify colon cancer patients with a favorable prognosis. American Journal of Pathology, 159(1), 297-304.
22.
Guttmacher, A., & Collins, F. (2005). Realizing the promise of genomics in biomedical research. Journal of theAmerican Medical Association, 294(11), 1399-1402.
23.
Guttmacher, A., Collins, F., & Carmona, R. (2005). The family history—More important than ever . The New England Journal of Medicine, 351(22), 2333-2336.
24.
Hadley, D., Jenkins, J., Dimond, E., de Carvalho, M., Kirsch, I., & Palmer, C. (2004). Colon cancer screening practices after genetic counseling and testing for nonhereditary nonpolyposis colorectal cancer. Journal ofClinical Oncology, 22(1), 39-44.
25.
Halvarsson, B., Lindblom, A., Rambech, E., Lagerstedt, K., & Nilbert, M. (2004). Microsatellite instability analysis and/or immunostaining for the diagnosis of hereditary nonpolyposis colorectal cancer? Virchows Archiv: An International Journal ofPathology, 444, 135-141.
26.
Hampel, H., Frankel, W., Martin, E., Arnold, M., Khanduja, K., & Kuebler, P. (2005). Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer). New England Journal of Medicine, 352(18), 1851-1860.
27.
Hendriks, Y., de Jong, A., Morreau, H., Tops, C., Vasen, H., Wijnen, J., et al. ( 2006). Diagnostic approach and management of Lynch syndrome (hereditary nonpolyposis colorectal carcinoma): A guide for clinicians. CA: A Cancer Journal for Clinicians, 56(4), 213-225.
28.
Jacob, S., & Praz, F. (2002). DNA mismatch repair defects: Role in colorectal carcinogenesis. Biochimie, 84, 27-47.
29.
Jarvinen, H., Aarnio, M., Mustonen, H., Aktan-Collan, K., Aaltonen, L., Peltomaki, P., et al. (2000). Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer . Gastroenterology, 118(5), 829-834.
30.
Jass, J. (2004). HNPCC and sporadic MSI-H colorectal cancer: A review of the morphologic similarities and differences. FamilialCancer, 3, 93-100.
31.
Jass, J. (2005). What's new in hereditary colorectal cancer?Archives of Pathology and Laboratory Medicine, 129, 1380-1384.
32.
Johnson, P., Gallinger, S., & McLeod, R. (2005). Surveillance colonoscopy in individuals at risk for hereditary nonpolyposis colorectal cancer: An evidence-based review. Diseases of the Colon and Rectum, 49, 80-95.
33.
Kievit, W., de Bruin, J., Adang, E., Ligtenberg, M., Nagengast, F., van Krieken, J., et al. (2004). Current clinical selection strategies for identification of hereditary non-polyposis colorectal cancer families are inadequate: A meta-analysis. Clinical Genetics, 65, 308-316.
34.
Kruhøffer, M., Jensen, J., Laiho, P., Dyrskjøt, L., Salovaara, R., Arango, D., et al. (2005). Gene expression signatures for colorectal cancer microsatellite status and HNPCC. British Journal of Cancer, 92, 2240-2248.
35.
Lackner, C., & Hoefler, G. (2005). Critical issues in the identification and management of patients with hereditary nonpolyposis colorectal cancer. EuropeanJournal of Gastroenterology and Hepatology, 17, 317-322.
36.
Lawes, D., Pearson, T., SenGupta, S., & Boulos, P. (2005). The role of MLH1, MSH2, and MSH6 in the development of multiple colorectal cancers. British Journal of Cancer , 93, 472-477.
37.
Lindor, N., Petersen, G., Hadley, D., Kinney, A., Miesfeldt, S., Lu, K., et al. (2006). Recommendations for the care of individuals with an inherited predisposition to Lynch syndrome. Journal of theAmerican Medical Association, 296(12), 1507-1517.
38.
Lynch, H., Boland, R., Gong, G., Shaw, T., Lynch, P., Fodde, R., et al. (2006). Phenotypic and genotypic heterogeneity in the Lynch syndrome: Diagnostic, surveillance and management implications. European Journal ofHuman Genetics, 14, 390-402.
39.
Lynch, H., & de la Chapelle, A. (2003). Hereditary colorectal cancer. New England Journal of Medicine, 348, 919-932.
40.
Lynch, H., Fusaro, R., & Lynch, P. (2006). Sebaceous skin lesions as clues to hereditary nonpolyposis colorectal cancer. Journal of InvestigativeDermatology, 126, 2158-2159.
41.
Lynch, H., & Lynch, J. (2005). What the physician needs to know about Lynch syndrome: An update. Oncology, 19(4), 455-469.
42.
Lynch, H., Riley, B., Weisman, S., Coronel, S., Kinarsky, Y., Lynch, J., et al. (2003). Hereditary nonpolyposis colorectal carcinoma (HNPCC) and HNPCC-like families: Problems in diagnosis, surveillance, and management. Cancer, 100(1), 53-64.
43.
Moss, E., Hollingworth, J., & Reynolds, T. (2005). The role of CA-125 in clinical practice. Journal of ClinicalPathology, 58, 308-312.
44.
Müller, A., Giuffre, G., Edmonston, T., Mathiak, M., Roggendorf, B., Heinmöller, E., et al. (2004). Challenges and pitfalls in HNPCC screening by microsatellite analysis and immunohistochemistry. Journal of Molecular Diagnostics, 6(4), 308-315.
45.
Müller, A., & Rishel, F. (2002). Mismatch repair and the hereditary non-polyposis colorectal cancer syndrome. Cancer Investigation, 20(1), 102-109.
46.
Murff, H., Spigel, D., & Syngal, S. (2004). Does this patient have a family history of cancer? Journal of theAmerican Medical Association, 292(12), 1480-1489.
47.
Olivier, R., Lubsen-Brandsma, M., Verhoef, S., & van Beurden, M. (2006). CA-125 and vaginal ultrasound monitoring in high-risk women cannot prevent the diagnosis of advanced ovarian cancer. Gynecologic Oncology, 100, 20-26.
48.
Peltomäki, P. (2005). Lynch syndrome genes. FamilialCancer, 4, 227-232.
49.
Pinol, V., Castells, A., Andreu, M., Castellví-Bel, S., Alenda, C., Llor, X., et al. (2005). Accuracy of revised Bethesda guidelines, microsatellite instability, and immunohistochemistry for the identification of patients with hereditary nonpolyposis colorectal cancer. Journal of theAmerican Medical Association, 293(16), 1986- 1994.
50.
Ponti, G., & Ponz de Leon, M. (2005). Muir-Torre syndrome. Lancet Oncology, 6, 980-987.
51.
Raevaara, T., Korhonen, M., Lohi, H., Hampel, H., Lynch, E., Lönnqvist, K., et al. (2005). Functional significance and clinical phenotype of non-truncating mismatch repair variants of MLH1. Gastroenterology , 129, 537-549.
52.
Samowitz, W., Curtin, K., Ma, K., Schaffer, D., Coleman, L., Leppert, M., et al. (2001). Microsatellite instability in sporadic colon cancer is associated with an improved prognosis at the population level . Cancer Epidemiology, Biomarkers & Prevention, 10, 917-923.
53.
Schiemann, U., Müller-Koch, Y., Gross, M., Daum, J., Lohse, P., Baretton, G., et al. (2003). Extended microsatellite analysis in microsatellite stable, MSH2 and MLH1 mutation-negative HNPCC patients: Genetic reclassification and correlation with clinical features. Digestion, 69, 166-176.
54.
Shia, J., Ellis, N., Paty, P., Nash, G., Qin, J., Offit, K., et al. (2003). Value of histopathology in predicting microsatellite instability in hereditary colorectal cancer and sporadic colorectal cancer. American Journal of SurgicalPathology, 27(11), 1407-1417.
55.
Sifri, R., Myers, R., Hyslop, T., Turner, B., Cocroft, J., Rothermel, T., et al. (2003). Use of cancer susceptibility testing among primary care physicians. Clinical Genetics, 64, 355-360.
56.
Stormorken, A., Bowitz-Lothe, I., Norè, T., Kure, E., Aase, S., Wijnen, J., et al. (2005). Immunohistochemistry identifies carriers of mismatch repair gene defects causing hereditary nonpolyposis colorectal cancer. Journal ofClinical Oncology, 23(21), 4705-4712.
57.
Strate, L., & Syngal, S. (2005). Hereditary colorectal cancer syndromes. Cancer Causes and Control, 16, 201-213.
58.
Suther, S., & Goodson, P. (2003). Barriers to the provision of genetic services by primary care physicians: A systematic review of the literature. Genetics in Medicine, 5(2), 70-76.
59.
Swisher, E. (2001). Hereditary cancers in obstetrics and gynecology. Clinical Obstetrics andGynecology, 44(3), 450-463.
60.
Terdiman, J. (2005). It is time to get serious about diagnosing Lynch syndrome (hereditary nonpolyposis colorectal cancer with defective DNA mismatch repair) in the general population. Gastroenterology, 129, 741-755.
61.
Terdiman, J., Levin, T., Allen, B., Gum, J., Fishbach, A., Conrad, P., et al. (2002). Hereditary nonpolyposis colorectal cancer in young colorectal cancer patients: High-risk clinic versus population-based registry. Gastroenterology, 122, 940-947.
62.
Umar, A., Boland, C., Terdiman, J., Syngal, S., de la Chapelle, A., Rüschoff, J., et al. (2004). Revised Bethesda Guidelines for hereditary non-polyposis colorectal cancer (Lynch Syndrome) and microsatellite instability. Journal of theNational Cancer Institute, 96(4), 261-268.
63.
Umar, A., Risinger, J., Hawk, E., & Barrett, C. (2004). Testing guidelines for hereditary non-polyposis colorectal cancer. Nature Reviews/Cancer, 4, 153-158.
64.
Vasen, H. (2005). Clinical description of the Lynch syndrome [hereditary nonpolyposis colorectal cancer (HNPCC)]. FamilialCancer, 4, 219-225.
65.
Vasen, H., & Boland, C.R. (2005). Progress in genetic testing, classification and identification of Lynch syndrome. Journal of theAmerican Medical Association, 16, 2028-2030.
66.
Wagner, A., Barrows, A., Wijnen, J., van der Klift, H., Franken, P., Verkuijlen, P., et al. (2003). Molecular analysis of HNPCC in the US: High mutation detection rate among clinically selected families and characterization of an American founder genomic deletion of the MSH2 gene. American Journal of Human Genetics, 72, 1088-1100.
